Wren capital investment bastion therapeutics seed round feb 2024?

When Did Bastion Therapeutics Close Its Seed Round?

In February 2024, [2] Wren Capital invested in Bastion Therapeutics, a biotech company focusing on rare diseases.

What Was the Focus of Bastion Therapeutics at the Time?

Bastion Therapeutics is a company that has developed a pipeline of product candidates focused on rare diseases.

How Has Wren Capital Contributed to the Industry?

Wren Capital, an investment firm, has been an active participant in the biotech sector, providing funding to companies working on innovative treatments. Their investment in Bastion Therapeutics highlights their commitment to rare disease research.

When Did They Close This Seed Round?

This investment was closed in February 2024.

Bastion Therapeutics Overview

Bastion Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on developing a pipeline of product candidates targeting rare diseases and cancer. They are based in South San Francisco.

Source

1. Wren Capital website
2. DrugPatentWatch.com - Bastion Therapeutics' news page